We have data on 771 companies that use Genome Analysis Toolkit. The companies using Genome Analysis Toolkit are most often found in United States and in the Biotechnology industry. Genome Analysis Toolkit is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Genome Analysis Toolkit usage goes back as far as 4 years and 4 months.
|Company||Regeneron Pharmaceuticals Inc|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, Genome Analysis Toolkit has a market share of about 0.4%. Other major and competing products in this category include:
The Genome Analysis Toolkit or GATK is a software package developed at the Broad Institute to analyze high-throughput sequencing data. The toolkit offers a variety of tools, with a primary focus on variant discovery and genotyping as well as strong emphasis on data quality assurance.
Looking at Genome Analysis Toolkit customers by industry, we find that Biotechnology (23%), Higher Education (21%), Hospital & Health Care (13%), Research (11%) and Information Technology and Services (5%) are the largest segments.
66% of Genome Analysis Toolkit customers are in United States.
Of all the customers that are using Genome Analysis Toolkit, a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 30% are medium-sized.
Of all the customers that are using Genome Analysis Toolkit, 43% are small (<$50M), 7% are medium-sized and 43% are large (>$1000M).